PARIS--(BUSINESS WIRE)--Medical device pioneer Stentys announced today that it has extended its ‘self-expanding’ and ‘disconnectable’ technology platform to include a second major indication—acute myocardial infarction (AMI). Two patients were successfully treated during acute myocardial infarction procedures last week by Drs. S. Verheye (Antwerp, Belgium) and K. E. Hauptmann (Trier, Germany).
